pharmaceutical investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
Maritime Resources: A Low-risk Path to Gold Production in One of the World’s Top Mining Jurisdictions
Homerun Resources Inc. Announces New Homerun Energy Website and "The Hub" AI-Powered Platform for Energy Management
